Randox is a leading provider of diagnostic reagents for the assessment of cardiovascular disease risk. Randox offer the most comprehensive lipid profile which includes both conventional risk factors as well as emerging biomarkers associated with an increased risk of cardiovascular disease:
- Direct HDL Cholesterol
- Direct LDL Cholesterol
- Total Cholesterol
- Triglycerides
- Lipoprotein(a)
- sLDL
- Apolipoprotein A-I
- Apolipoprotein A-II
- Apolipoprotein B
- Apolipoprotein C-II
- Apolipoprotein C-III
- Apolipoprotein E
- Homocysteine
Further to this market leading offering, Randox lipid reagents offer superior performance through advanced methodologies and limited interference, ensuring accurate results are returned, even with abnormal patient samples. The Randox lipid portfolio is also available for use on an extensive range of clinical chemistry analyzers via a wide range of instrument specific applications, providing optimum flexibility and ease of use.
